Company

Myonexus Therapeutics, Inc.

New Albany company developing gene therapies for rare muscular dystrophies, acquired by Sarepta Therapeutics in February 2019.

About

Founded in 2017 and headquartered in New Albany, US, Myonexus Therapeutics, Inc. develops gene therapies for rare muscular dystrophies, aimed at patients with unmet medical needs. Sarepta Therapeutics, Inc. acquired the company for USD 165 mn in February 2019. As part of Sarepta, it sells its therapies mainly to hospitals and healthcare providers that treat these conditions, and it plans to expand into Europe and Asia by the end of 2024.

3Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in